# NEXUS BIOPHARMA INC

NEXUS BIOPHARMA INC is a company headquartered in Houston, TX, United States.

## Company overview

- **Legal name:** NEXUS BIOPHARMA INC
- **Former names in filing history:** Plata Resources, Inc. (2008-02-01 to 2016-05-18)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Houston, TX, United States
- **Fiscal year end:** February 28
- **SEC CIK:** 0001424151

## About

NEXUS BIOPHARMA INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001424151, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2017-07-05, it reported net income of USD -686,100; total assets of USD 9,527 for the fiscal period ended 2017-02-28. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-02-28)

- **Net income:** -$686,100 (USD -686,100)
- **Total assets:** $9,527 (USD 9,527)
- **Cash and equivalents:** $77 (USD 77)

### FY2015 (period ended 2015-12-31)

- **Net income:** -$41,846 (USD -41,846)
- **Total assets:** $0 (USD 0)

### FY2014 (period ended 2014-12-31)

- **Net income:** -$1,400 (USD -1,400)
- **Total assets:** $5,000 (USD 5,000)

### FY2013 (period ended 2013-12-31)

- **Net income:** -$15,261 (USD -15,261)
- **Total assets:** $0 (USD 0)
- **Operating cash flow:** -$369 (USD -369)

## Recent SEC filings

- Form 10-Q — filed 2017-10-27 — period 2017-05-31 — QUARTERLY REPORT
- Form 10-K — filed 2017-07-05 — period 2017-02-28 — ANNUAL REPORT
- Form 8-K — filed 2017-05-17 — period 2017-05-17 — CURRENT REPORT
- Form 10-Q — filed 2017-04-10 — period 2016-11-30 — FORM 10-Q QUARTERLY REPORT
- Form 8-K — filed 2017-03-16 — period 2017-03-08 — FORM 8-K CURRENT REPORT
- Form 8-K — filed 2017-01-03 — period 2016-12-20 — FORM 8-K CURRENT REPORT
- Form DEF 14A — filed 2016-11-16 — period 2016-11-16 — REVISED PRELIMINARY 14A PROXY STATEMENT
- Form 10-Q — filed 2016-10-24 — period 2016-08-31 — QUARTERLY REPORT
- Form 8-K — filed 2016-10-14 — period 2016-10-07 — FORM 8-K CURRENT REPORT
- Form SC 13G — filed 2016-07-08 — SCHEDULE 13G
- Form SC 13G — filed 2016-06-20 — SCHEDULE 13G
- Form SC 13G — filed 2016-06-20 — SCHEDULE 13G

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/nexus-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology